# EPIVIR
> **NDA020564** · New Drug Application · Sponsor: VIIV HLTHCARE · Approved 2004-11-22
## Drug
- **FDA Application Number:** NDA020564
- **Application type:** New Drug Application
- **Brand name:** EPIVIR
- **Generic name:** LAMIVUDINE
- **Active ingredients:** LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** VIIV HLTHCARE
- **Manufacturer:** ViiV Healthcare Company
- **First approval:** 2004-11-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020564)
---
*AI Analytics · CC0 1.0*